Funded Startups in Gaithersburg
The largest disclosed round in the Gaithersburg list is Cartesian Therapeutics’ $50M on 2026-05-26; every other disclosed amount shown is at or below $225M…
The largest disclosed round in the Gaithersburg list is Cartesian Therapeutics’ $50M on 2026-05-26; every other disclosed amount shown is at or below $225M, with Altimmune’s $225M (2026-04-22) the next-highest disclosure and no other single round approaching that same upper band. Most entries cluster in late 2025 through 2026: 8 of the 21 rows have round dates between 2025-05-13 and 2026-06-05, while the oldest shown round dates back to 2020-09-09 (Xometry).
Biotechnology dominates the sector mix: 14 of 21 entries list Biotechnology, while non-biotech categories are more fragmented across Hardware (Robotic Research, 2024-09-10; $75M), Agriculture and Farming (Silvec Biologics, 2025-06-10; $100K), Manufacturing (Euclid TechLabs, 2023-08-16; undisclosed), Health Care (LKC Technologies, 2023-06-12; undisclosed), Apps (Givhero, 2023-03-22; $400K), Consumer Electronics (School-Pass, 2021-11-12; $16M), and Commerce and Shopping (Xometry, 2020-09-09; $75M). Stage labels are incomplete or generalized: 14 of 21 rows are “Series Unknown,” and 2 entries are explicitly “undisclosed” (Certify Health, 2025-05-13; Euclid TechLabs, 2023-08-16).
Most recent rounds
21 shownRelated listings
Frequently asked
What’s the biggest disclosed round in Gaithersburg here, and how separated is it from the rest of the disclosed amounts?
Altimmune disclosed $225M on 2026-04-22, and Cartesian Therapeutics disclosed $50M on 2026-05-26; other disclosed rounds shown include $100M (Robotic Research, 2024-09-10 is $75M; Georgiamune is $75M), plus smaller figures like $2M (Amplexd Therapeutics, 2024-05-20) and $18M (Remedy Plan Therapeutics, 2025-05-13). The $225M disclosure sits in a distinctly higher range than the next-largest disclosed amount.
Do the most recent rounds cluster tightly in time, or are they evenly spread across the full window shown?
They cluster toward the recent period: 8 of 21 rounds fall between 2025-05-13 (Certify Health) and 2026-06-05 (Lentigen). The window then stretches back to 2020-09-09 (Xometry), indicating a long tail of older activity with heavy concentration in the last ~14–15 months shown.
Which sector is most over-represented, and how do the non-biotech entries look by comparison?
Biotechnology accounts for 14 of 21 entries (for example, Lentigen on 2026-06-05 at $500K and Arcellx on 2022-12-09 at $100M). The remaining 7 entries are split across Hardware (Robotic Research, 2024-09-10; $75M), Consumer Electronics (School-Pass, 2021-11-12; $16M), Apps (Givhero, 2023-03-22; $400K), and other singletons like Commerce and Shopping (Xometry, 2020-09-09; $75M).
How incomplete are the stage disclosures, and what’s the mix between labeled stages and “Series Unknown”/undisclosed?
Stage labels are dominated by “Series Unknown,” which appears in 14 of 21 rows (e.g., Cartesian Therapeutics, 2026-05-26; $50M). Labeled stages appear in several biotech entries (such as Sensei Biotherapeutics, Series B on 2021-01-11; $30M, and Georgiamune, Series A on 2023-08-09; $75M), while 2 rows are explicitly “undisclosed” (Certify Health, 2025-05-13; Euclid TechLabs, 2023-08-16).
Are there notable outliers in sector or deal size you’d screen first?
On deal size, Altimmune’s $225M (2026-04-22) is the top disclosed amount in this slice, followed by Cartesian Therapeutics’ $50M (2026-05-26) and multiple $75M disclosures like Robotic Research (2024-09-10) and Georgiamune (2023-08-09). On deal-size floors, the smallest disclosed amount is $100K (Silvec Biologics, 2025-06-10), with another low disclosure at $400K (Givhero, 2023-03-22), indicating a wide spread rather than a tight band.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.